Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Weigel · SciRah

Researcher profile · Semantic Scholar

B. Weigel

Share profile

B. Weigel — researcher profile on SciRah

h-index: 45
Works: 179
Citations: 7,499

Most-cited papers

Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.
Y. Mossé, S. Voss, M. Lim, D. Rolland +6 more
2017Journal of Clinical Oncology370 citations Open access
Semantic Scholar
Nivolumab in children and young adults with relapsed/refractory solid tumors (ADVL1412): A Phase 1 / 2 Trial
K. Davis, E. Fox, M. Merchant, J. Reid +7 more
2020The Lancet Oncology267 citations Open access
Semantic Scholar
Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
B. Weigel, E. Lyden, James R. Anderson, W. Meyer +5 more
2016Journal of Clinical Oncology181 citations Open access
Semantic Scholar
Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.
Joanne P Lagmay, M. Krailo, H. Dang, AeRang Kim +11 more
2016Journal of Clinical Oncology165 citations Open access
Semantic Scholar
Historical time-to-progression (TTP) and progression-free survival (PFS) in relapsed/refractory neuroblastoma modern-era (2002-14) patients from Children’s Oncology Group (COG) early-phase trials
W. London, R. Bagatell, B. Weigel, E. Fox +4 more
2017Cancer154 citations Open access
Semantic Scholar
Activity of Crizotinib in Patients with ALK-aberrant Relapsed/Refractory Neuroblastoma: A Children’s Oncology Group Study (ADVL0912)
Jennifer H. Foster, S. Voss, David Hall, C. Minard +8 more
2021Clinical Cancer Research104 citations Open access
Semantic Scholar
Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children’s Oncology Group
E. Rudzinski, James R. Anderson, Yueh-Yun Chi, J. Gastier-Foster +10 more
2017Pediatric Blood & Cancer104 citations Open access
Semantic Scholar
A Phase 2 Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children’s Oncology Group Phase 1 and Pilot Consortium (ADVL0921)
Y. Mossé, E. Fox, D. Teachey, J. Reid +12 more
2019Clinical Cancer Research97 citations Open access
Semantic Scholar
The Addition of Cixutumumab or Temozolomide to Intensive Multiagent Chemotherapy Is Feasible but Does Not Improve Outcome for Patients with Metastatic Rhabdomyosarcoma: A Report from the Children’s Oncology Group
S. Malempati, B. Weigel, Yueh-Yun Chi, Jing Tian +9 more
2018Cancer85 citations Open access
Semantic Scholar
A Phase I Trial and Viral Clearance Study of Reovirus (Reolysin) in Children with Relapsed or Refractory Extra-cranial Solid Tumors: A Children's Oncology Group Phase I Consortium Report
E. A. Kolb, Valerie B. Sampson, D. Stabley, Alexa Walter +7 more
2015Pediatric Blood & Cancer78 citations Open access
Semantic Scholar
Brentuximab vedotin with Gemcitabine for Pediatric and Young Adult Patients with Relapsed or Refractory Hodgkin Lymphoma: A Children’s Oncology Group, Single-arm, Phase 1 / 2 Trial.
P. Cole, K. McCarten, Q. Pei, M. Spira +7 more
2018The Lancet Oncology75 citations Open access
Semantic Scholar
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.
A. Pearson, C. Rossig, G. Lesa, S. Diede +41 more
2020European Journal of Cancer60 citations Open access
Semantic Scholar
A Phase 1 Study of Cabozantinib in Children and Adolescents with Recurrent or Refractory Solid Tumors, Including CNS Tumors: Trial ADVL1211, A Report from the Children’s Oncology Group
Meredith K. Chuk, B. Widemann, C. Minard, Xiao-Wei Liu +8 more
2018Pediatric Blood & Cancer60 citations Open access
Semantic Scholar
A Phase I/II Trial of Nivolumab Plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children’s Oncology Group Study ADVL1412
K. Davis, E. Fox, Emasenyie Isikwei, J. Reid +6 more
2022Clinical Cancer Research59 citations Open access
Semantic Scholar
Successful management of an arteriovenous malformation with trametinib in a patient with capillary‐malformation arteriovenous malformation syndrome and cardiac compromise
C. Nicholson, S. Flanagan, Michael Murati, Christina Boull +4 more
2022Pediatric dermatology59 citations
Semantic Scholar
Phase 1/2 Trial of Vorinostat and Radiation and Maintenance Vorinostat in Children with Diffuse Intrinsic Pontine Glioma: A Children's Oncology Group Report.
J. Su, L. Kilburn, D. Mansur, M. Krailo +8 more
2021Neuro-Oncology55 citations Open access
Semantic Scholar
Phase I Clinical Trial of the Wee1 inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors. A COG Phase 1 Consortium Report (ADVL1312)
K. Cole, Sharmistha Pal, Rachel A. Kudgus, Heba Ijaz +10 more
2019Clinical Cancer Research53 citations Open access
Semantic Scholar
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
A. Pearson, Elly Barry, Y. Mossé, Franca Ligas +40 more
2021European Journal of Cancer47 citations Open access
Semantic Scholar
ACCELERATE - Five years accelerating cancer drug development for children and adolescents.
A. Pearson, S. Weiner, P. Adamson, Dominik Karres +21 more
2022European Journal of Cancer40 citations Open access
Semantic Scholar
ADVL1412: Initial results of a phase I/II study of nivolumab and ipilimumab in pediatric patients with relapsed/refractory solid tumors—A COG study.
K. Davis, E. Fox, J. Reid, Xiao-Wei Liu +3 more
201738 citations
Semantic Scholar
A Phase I Study of Entinostat in Children and Adolescents with Recurrent or Refractory Solid Tumors, Including CNS Tumors: Trial ADVL1513, Pediatric Early Phase-Clinical Trial Network (PEP-CTN)
A. Bukowinski, B. Chang, J. Reid, Xiao-Wei Liu +5 more
2021Pediatric Blood & Cancer36 citations Open access
Semantic Scholar
Associations of Socioeconomic Status, Public vs Private Insurance, and Race/Ethnicity With Metastatic Sarcoma at Diagnosis
Brandon J. Diessner, B. Weigel, P. Murugan, Lin Zhang +2 more
2020JAMA Network Open36 citations Open access
Semantic Scholar
A Phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children’s Oncology Group study (ADVL1114)
S. Rheingold, Sarah K. Tasian, J. Whitlock, D. Teachey +6 more
2017British Journal of Haematology35 citations Open access
Semantic Scholar
First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot Consortium
F. Balis, P. Thompson, Y. Mossé, S. Blaney +3 more
2016Cancer Chemotherapy and Pharmacology35 citations Open access
Semantic Scholar
A Phase 1 Study of Prexasertib (LY2606368), a CHK1/2 Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS Tumors: A Report from the Children’s Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515)
T. Cash, E. Fox, Xiao-Wei Liu, C. Minard +4 more
2021Pediatric Blood & Cancer34 citations Open access
Semantic Scholar
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
A. Pearson, C. Rossig, C. Mackall, N. Shah +50 more
2021European Journal of Cancer32 citations Open access
Semantic Scholar
ADVL1522: A Phase 2 Study of Lorvotuzumab Mertansine (IMGN901) in Children with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor (MPNST) and Synovial Sarcoma, a Children’s Oncology Group Study
J. Geller, J. Pressey, Malcolm A. Smith, Rachel A. Kudgus +10 more
2020Cancer32 citations Open access
Semantic Scholar
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma
K. Cole, Heba Ijaz, L. Surrey, M. Santi +7 more
2023Cancer27 citations Open access
Semantic Scholar
Metabolic response as assessed by 18F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
D. Harrison, Yueh-Yun Chi, Jing Tian, P. Hingorani +14 more
2020Cancer Medicine27 citations Open access
Semantic Scholar
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1)
E. Raetz, D. Teachey, C. Minard, Xiao-Wei Liu +9 more
2023Pediatric Blood & Cancer25 citations Open access
Semantic Scholar
Phase 2 trial of cabozantinib in children and young adults with refractory sarcomas, Wilms tumor, and rare tumors: Children's Oncology Group Study (ADVL1622).
S. Akshintala, B. Widemann, D. Barkauskas, David Hall +5 more
202125 citations
Semantic Scholar
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children’s Oncology Group phase 1 consortium study (ADVL1212)
E. Greengard, Y. Mossé, Xiao-Wei Liu, C. Minard +8 more
2020Cancer Chemotherapy and Pharmacology24 citations Open access
Semantic Scholar
Safety and efficacy of gamma‐secretase inhibitor nirogacestat (PF‐03084014) in desmoid tumor: Report of four pediatric/young adult cases
Takuto Takahashi, J. Prensner, C. Robson, Katherine A. Janeway +1 more
2020Pediatric Blood & Cancer24 citations
Semantic Scholar
Phase 1 Trial of Ontuxizumab (MORAb-004) in Children with Relapsed or Refractory Solid tumors: A Report from the Children’s Oncology Group Phase 1 Pilot Consortium (ADVL1213)
R. Norris, E. Fox, J. Reid, Andrew T. Ralya +3 more
2018Pediatric Blood & Cancer24 citations Open access
Semantic Scholar
Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children’s Oncology Group
Abha A. Gupta, Yueh-Yun Chi, James R. Anderson, E. Lyden +5 more
2017Pediatric Blood & Cancer24 citations Open access
Semantic Scholar
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children’s Oncology Group phase I consortium study
S. Mueller, Tabitha Cooney, Xiao-Dong Yang, Sharmistha Pal +10 more
2022Neuro-Oncology Advances19 citations Open access
Semantic Scholar
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
A. Pearson, Sara M. Federico, S. Gatz, M. Ortiz +37 more
2023European Journal of Cancer18 citations Open access
Semantic Scholar
Prognostic Factors for Development of Subsequent Metastases in Localized Osteosarcoma: A Systematic Review and Identification of Literature Gaps
Patrick Basile, E. Greengard, B. Weigel, L. Spector
2020Sarcoma16 citations Open access
Semantic Scholar
A phase 1 study of eribulin mesylate (E7389), a novel microtubule targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: a Children’s Oncology Group Phase 1 Consortium study (ADVL1314)
E. Schafer, R. Rau, S. Berg, Xiao-Wei Liu +10 more
2018Pediatric Blood & Cancer16 citations Open access
Semantic Scholar
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
A. Pearson, N. Gaspar, Katherine A. Janeway, Q. Campbell-Hewson +39 more
2022European Journal of Cancer15 citations Open access
Semantic Scholar
Racial and ethnic differences in sarcoma incidence are independent of census-tract socioeconomic status.
Brandon J. Diessner, B. Weigel, P. Murugan, Lin Zhang +2 more
2020Cancer Epidemiology, Biomarkers and Prevention15 citations Open access
Semantic Scholar
Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report
Behzad Bidadi, Andrea M Watson, B. Weigel, Andre M. Oliveira +2 more
2020Pediatric Blood & Cancer14 citations
Semantic Scholar
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents
L. Moreno, S. DuBois, J. Glade Bender, A. Mauguen +21 more
2023Journal of Clinical Oncology13 citations Open access
Semantic Scholar
Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning
Kelly M. Makielski, Alicia J. Donnelly, A. Khammanivong, M. Scott +17 more
2021bioRxiv13 citations Open access
Semantic Scholar
A phase I trial and pharmacokinetic study of IMC-A12 in pediatric patients with relapsed/refractory solid tumors: A Children's Oncology Group Phase I Consortium study.
S. Malempati, B. Weigel, A. Ingle, C. Ahern +6 more
2016Journal of Clinical Oncology13 citations
Semantic Scholar
Rhabdomyosarcoma with Isolated Lung Metastases: A Report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group
Juan C. Vasquez, Leo Y. Luo, S. Hiniker, D. Rhee +6 more
2023Pediatric Blood & Cancer12 citations Open access
Semantic Scholar
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
A. Pearson, Carl E. Allen, J. Fangusaro, C. Hutter +34 more
2022European Journal of Cancer12 citations Open access
Semantic Scholar
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: A Report from the Children's Oncology Group
E. Stieglitz, Alex G. Lee, Steven P. Angus, Christopher Davis +10 more
2023Blood11 citations Open access
Semantic Scholar
18F 2Fluoro-2deoxy-D-glucose positron emission tomography (FDG-PET) response to predict event-free survival (EFS) in intermediate risk (IR) or high risk (HR) rhabdomyosarcoma (RMS): A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group (COG).
D. Harrison, M. Parisi, B. Shulkin, Yueh-Yun Chi +14 more
201611 citations
Semantic Scholar
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia
E. Stieglitz, Alex G. Lee, Steven P. Angus, Christopher Davis +11 more
2024Cancer Discovery10 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Fox×22
Invite
E. Fox — researcher profile on SciRah
C. Minard×16
Invite
C. Minard — researcher profile on SciRah
J. Reid×16
Invite
J. Reid — researcher profile on SciRah
Xiao-Wei Liu×14
Invite
Xiao-Wei Liu — researcher profile on SciRah

×13

Invite

S. Blaney — researcher profile on SciRah

Invite

S. Voss — researcher profile on SciRah

Invite

D. Hawkins — researcher profile on SciRah

Invite

E. Fox — researcher profile on SciRah

Invite

G. Vassal — researcher profile on SciRah

Invite

S. Berg — researcher profile on SciRah

Invite

S. Weiner — researcher profile on SciRah

Invite

L. Marshall — researcher profile on SciRah